Antiviral agents for the treatment of COVID-19: Progress and challenges

Cell Rep Med. 2022 Feb 11;3(3):100549. doi: 10.1016/j.xcrm.2022.100549. eCollection 2022 Mar 15.

Abstract

The COVID-19 pandemic has seen clinical development and use of antiviral therapies at an unprecedented speed. Antiviral therapies have greatly improved the clinical outcome in COVID-19 patients, especially when administered early after diagnosis. Here, we discuss the successes and challenges of COVID-19 antiviral therapies and lessons for future pandemics.

Publication types

  • News

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19 Drug Treatment*
  • Forecasting
  • Humans
  • Influenza, Human* / drug therapy
  • Pandemics

Substances

  • Antiviral Agents